Cargando…
Secondary acute myeloid leukemia after successful treatment for osteosarcoma
Secondary acute myeloid leukemia (sAML) is a rare complication following chemotherapy for osteogenic sarcoma. However, the exact offending drug is difficult to prove as there is no consistent data. It usually develops 2 years after completion of therapy. We report a case of sAML that developed withi...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941602/ https://www.ncbi.nlm.nih.gov/pubmed/20931020 http://dx.doi.org/10.4103/0971-5851.68852 |